IBT — International Biotechnology Trust Share Price
Last trade - 00:00- £192.32m
- £204.72m
- £44.54m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.68 | ||
| Price to Tang. Book | 0.68 | ||
| Price to Free Cashflow | 4.24 | ||
| Price to Sales | 4.32 | ||
| EV to EBITDA | 5.25 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.82% | ||
| Return on Equity | 14.07% | ||
| Operating Margin | 87.59% | ||
Financial Summary
| Year End 31st Aug | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 57.03 | 32.09 | -17.96 | 12.06 | 44.54 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -50.43 | n/a | n/a | +506.46 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
International Biotechnology Trust plc is a United Kingdom-based investment trust company. The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company seeks to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialization of a product, device or enabling technology. The Company’s investments may also be made in related sectors, such as medical devices and healthcare services. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. SV Health Managers LLP is the Company's alternative investment fund manager (AIFM).
Directors
- Last Annual
- August 31st, 2024
- Last Interim
- August 31st, 2024
- Incorporated
- January 31st, 1994
- Public Since
- February 22nd, 1996
- Sector
- Collective Investments
- Industry
- Financials
- Exchange
- London Stock Exchange
- Shares in Issue
- 35,223,700
- Address
- 6th Floor, 65 Gresham Street,, LONDON, EC2V 7NQ
- Web
- https://www.schroders.com/en-gb/uk/individual/funds-and-strategies/investment-trusts/international-biotechnology-trust/
- Phone
- +44 2074217070
- Auditors
- PricewaterhouseCoopers LLP
Latest News for IBT
Upcoming Events for IBT
Half Year 2025 International Biotechnology Trust PLC Earnings Release
Similar to IBT
3i Infrastructure
London Stock Exchange
Aberforth Geared Value & Income Trust
London Stock Exchange
Aberforth Smaller Companies Trust
London Stock Exchange
Abrdn Asia Focus
London Stock Exchange
abrdn Asian Income Fund
London Stock Exchange
FAQ
As of Today at 21:20 UTC, shares in International Biotechnology Trust are trading at 546.00p. This share price information is delayed by 15 minutes.
Shares in International Biotechnology Trust last closed at 546.00p and the price had moved by -12.08% over the past 365 days. In terms of relative price strength the International Biotechnology Trust share price has underperformed the FTSE All Share Index by -15.53% over the past year.
The overall consensus recommendation for International Biotechnology Trust is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe International Biotechnology Trust dividend yield is 5.51% based on the trailing twelve month period.
Last year, International Biotechnology Trust paid a total dividend of £0.30, and it currently has a trailing dividend yield of 5.51%. We do not have any data on when International Biotechnology Trust is to next pay dividends.
We do not have data on when International Biotechnology Trust is to next pay dividends. The historic dividend yield on International Biotechnology Trust shares is currently 5.51%.
To buy shares in International Biotechnology Trust you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 546.00p, shares in International Biotechnology Trust had a market capitalisation of £192.32m.
Here are the trading details for International Biotechnology Trust:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: IBT
Based on an overall assessment of its quality, value and momentum International Biotechnology Trust is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like International Biotechnology Trust. Over the past six months, its share price has underperformed the FTSE All Share Index by -21.42%.
As of the last closing price of 546.00p, shares in International Biotechnology Trust were trading -19.38% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The International Biotechnology Trust PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 546.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
International Biotechnology Trust's management team is headed by:
- Jim Horsburgh - NEC
- Kate Cornish-Bowden - NID
- Caroline Gulliver - NID
- Patrick Magee - NID